Five diagnosed prevalent cases will grow to over 714,000. Diagnosed incident cases of B-cell non-Hodgkin’s lymphoma (B-cell ...

A next-generation "armored" CAR T cell therapy showed promising results in a small study of patients whose B-cell lymphomas ...

Dr. Neha Mehta-Shah shares how patients can better understand their subtype of rare lymphoma, as well as expands on the ...

Mike Peters, the frontman for the Welsh band The Alarm, has died at the age of 66. Peters’ death was announced by the charity ...

Arvinas, Inc. announced promising preclinical results for ARV-393, a targeted protein degrader aimed at treating non-Hodgkin lymphoma, particularly high grade B-cell lymphomas. Data showed that ...

FOX CHASE (WPVI) -- We often connect cancer to one part of the body. Lymphoma, however, can attack almost anywhere. But a treatment pioneered here in Philadelphia is rapidly improving the odds for ...

This approval marks the application of the therapy to a wider range of individuals with lymphoma. The therapy is now approved for three indications: relapsed and refractory (R/R) CLL/SLL, R/R marginal ...

BCL2 translocations were lacking in all the cases. Bcl2-positive GCs in PCT are a rare and benign phenomenon, expanding the spectrum of lymphoma-mimicking paediatric RLH.

Epcoritimab is a treatment for diffuse large B-cell lymphoma, a form of Non-Hodgkin lymphoma affecting 2000 Australians annually and characterised by its aggressive growth. Set to be subsidised by ...

TULSA, Okla. — They call Share House one of Tulsa's best-kept secrets. It's a one-stop furniture shop for those in need. It helps breathe a little comfort and life into a new apartment or house ...

“We miss our New Mexican roots, miss home,” she said from a Zoom call. “It was not an easy, decision that I made. I’m going to try not to get emotional.” Maestas moved to Missouri ...